Antitumor agent-175 (Compound Ru2) is a chemotherapeutic agent with photocytotoxic properties, selectively targeting triple-negative breast cancer (TNBC) cells for enhanced antitumor effectiveness.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
